Petr Zatloukal

Summary

Affiliation: Charles University
Country: Czech Republic

Publications

  1. ncbi request reprint Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Charles University, 3rd Faculty of Medicine, University Hospital Na Bulovce, Budinova 2, 18081 Prague, Czech Republic
    Lung Cancer 41:283-93. 2003
  2. ncbi request reprint Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, 3rd Faculty of Medicine, Faculty Hospital Bulovka, Charles University, Budinova 2, 18081 Prague, Czech Republic
    Lung Cancer 46:87-98. 2004
  3. ncbi request reprint Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Postgraduate Medical School, 3rd Faculty of Medicine, Charles University, Budinova 2, Prague 180 81, Czech Republic
    Lung Cancer 41:321-31. 2003
  4. ncbi request reprint Highlights from the 7th central European lung cancer conference
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Faculty Hospital Na Bulovce, Charles University and Postgraduate Medical School, Budinova 2, 18081 8, Prague, Czech Republic
    Lung Cancer 37:103-8. 2002
  5. doi request reprint Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, 3rd Faculty of Medicine, Charles University, Faculty Hospital Bulovka and Postgraduate Medical School, Praha, Czech Republic
    J Thorac Oncol 3:894-901. 2008
  6. ncbi request reprint Lung cancer risk among Czech women: a case-control study
    Antonín K Kubík
    Department of Pneumology and Thoracic Surgery, Charles University, Third Faculty of Medicine, University Hospital Na Bulovce, Budinova 2, 18081 Prague, Czech Republic or
    Prev Med 34:436-44. 2002
  7. ncbi request reprint Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Third Medical Faculty of Charles University, Postgraduate Medical School and Faculty, Hospital Na Bulovce, Budinova 2, Prague 180 81, Czech Republic
    Lung Cancer 38:S33-6. 2002
  8. ncbi request reprint Lung cancer in women
    Norbert Pauk
    Department of Pneumology and Thoracic Surgery, Charles University, 3rd Faculty of Medicine, University Hospital Na Bulovce, and Postgraduate Medical Institute, Budinova 2, 18081 Prague, Czech Republic
    Lung Cancer 48:1-9. 2005
  9. ncbi request reprint Expression of apoptosome pathway-related transcripts in non-small cell lung cancer
    Evzen Krepela
    Clinic of Pneumology and Thoracic Surgery, University Hospital Bulovka and 3rd Faculty of Medicine, Charles University, Budinova 2, 180 81, Prague 8, Czech Republic
    J Cancer Res Clin Oncol 132:57-68. 2006
  10. ncbi request reprint Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
    Evzen Krepela
    Laboratories of Molecular and Cell Biology, University Hospital Bulovka, Prague, Czech Republic
    Int J Oncol 35:1449-62. 2009

Detail Information

Publications15

  1. ncbi request reprint Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Charles University, 3rd Faculty of Medicine, University Hospital Na Bulovce, Budinova 2, 18081 Prague, Czech Republic
    Lung Cancer 41:283-93. 2003
    ..28). Inverse associations with the risk of squamous-, small- and large-cell cancers combined emerged for the quantity of menstrual flow (OR=0.63, 95%CI 0.40-0.99), and pains or mental tension related to menses (OR=0.61, 95%CI 0.42-0.89)...
  2. ncbi request reprint Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, 3rd Faculty of Medicine, Faculty Hospital Bulovka, Charles University, Budinova 2, 18081 Prague, Czech Republic
    Lung Cancer 46:87-98. 2004
    ..This study compared the safety and efficacy of concurrent and sequential CRT, with chemotherapy (CT) consisting of a cisplatin and vinorelbine regimen, in patients with locally advanced NSCLC...
  3. ncbi request reprint Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Postgraduate Medical School, 3rd Faculty of Medicine, Charles University, Budinova 2, Prague 180 81, Czech Republic
    Lung Cancer 41:321-31. 2003
    ..Secondary objectives were to evaluate response, duration of response, time to progressive disease (TTPD), and survival...
  4. ncbi request reprint Highlights from the 7th central European lung cancer conference
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Faculty Hospital Na Bulovce, Charles University and Postgraduate Medical School, Budinova 2, 18081 8, Prague, Czech Republic
    Lung Cancer 37:103-8. 2002
  5. doi request reprint Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, 3rd Faculty of Medicine, Charles University, Faculty Hospital Bulovka and Postgraduate Medical School, Praha, Czech Republic
    J Thorac Oncol 3:894-901. 2008
    ....
  6. ncbi request reprint Lung cancer risk among Czech women: a case-control study
    Antonín K Kubík
    Department of Pneumology and Thoracic Surgery, Charles University, Third Faculty of Medicine, University Hospital Na Bulovce, Budinova 2, 18081 Prague, Czech Republic or
    Prev Med 34:436-44. 2002
    ..Few data are available to explain the ongoing increase in lung cancer mortality among Czech women. The study is aimed at examining the role of smoking and known or suspected cofactors...
  7. ncbi request reprint Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Petr Zatloukal
    Department of Pneumology and Thoracic Surgery, Third Medical Faculty of Charles University, Postgraduate Medical School and Faculty, Hospital Na Bulovce, Budinova 2, Prague 180 81, Czech Republic
    Lung Cancer 38:S33-6. 2002
    ..A better understanding of the relative toxicities of these regimens should be provided by the final results of this trial...
  8. ncbi request reprint Lung cancer in women
    Norbert Pauk
    Department of Pneumology and Thoracic Surgery, Charles University, 3rd Faculty of Medicine, University Hospital Na Bulovce, and Postgraduate Medical Institute, Budinova 2, 18081 Prague, Czech Republic
    Lung Cancer 48:1-9. 2005
    ..Since tobacco is far and away the strongest epidemiological risk factor for the development of lung cancer, comprehensive smoking control efforts are the priority in the prevention of lung cancer among women...
  9. ncbi request reprint Expression of apoptosome pathway-related transcripts in non-small cell lung cancer
    Evzen Krepela
    Clinic of Pneumology and Thoracic Surgery, University Hospital Bulovka and 3rd Faculty of Medicine, Charles University, Budinova 2, 180 81, Prague 8, Czech Republic
    J Cancer Res Clin Oncol 132:57-68. 2006
    ....
  10. ncbi request reprint Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
    Evzen Krepela
    Laboratories of Molecular and Cell Biology, University Hospital Bulovka, Prague, Czech Republic
    Int J Oncol 35:1449-62. 2009
    ....
  11. ncbi request reprint Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis
    Andrea Ardizzoni
    Division of Medical Oncology, University Hospital, Via Gramsci 14, 43100 Parma, Italy
    J Natl Cancer Inst 99:847-57. 2007
    ..Because the efficacy of carboplatin and cisplatin in the treatment of advanced non-small-cell lung cancer (NSCLC) has not been proven to be equivalent, an individual patient data meta-analysis comparing the two treatments was performed...
  12. doi request reprint Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I
    Rodryg Ramlau
    Lung Disease Centre, Oncology Department, ul Szamarzewskiego, Poznan, Poland
    J Clin Oncol 26:1886-92. 2008
    ..This study evaluated whether the combination of the synthetic rexinoid bexarotene with first-line cisplatin/vinorelbine therapy provides additional survival benefit in patients with advanced non-small-cell lung cancer (NSCLC)...
  13. doi request reprint Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide
    Robert Pirker
    Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    J Clin Oncol 26:2342-9. 2008
    ....
  14. doi request reprint Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study
    Lucio Crino
    Department of Medical Oncology, Perugia Hospital, S Andrea delle Fratte, 06156 Perugia, Italy
    J Clin Oncol 26:4253-60. 2008
    ..This phase II, open-label, parallel-group study compared gefitinib with vinorelbine in chemotherapy-naïve elderly patients with advanced non-small-cell lung cancer (NSCLC)...
  15. ncbi request reprint Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)
    Giuseppe Giaccone
    Division of Medical Oncology, Vrije Universiteit Medical Center, 1117 De Boelelaan, Amsterdam, The Netherlands
    J Clin Oncol 23:6854-64. 2005
    ..We assessed whether Bec2/bacille Calmette-Guerin (BCG) vaccination prolongs survival in patients with limited-disease small-cell lung cancer (SCLC) after a major response to chemotherapy and chest radiation...